Carvedilol 12.5 MG

DRUG3 trials

Sponsors

Beijing Friendship Hospital, Institute of Liver and Biliary Sciences, India, Kafrelsheikh University

Conditions

Acute on Chronic Liver FailureArterial HypertensionLiver CirrhosisPortal Hypertension

Phase 4

Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients

CompletedNCT07397481

Kafrelsheikh UniversityArterial Hypertension, Liver Cirrhosis

Start: 2024-03-01End: 2025-06-01Updated: 2026-02-09

Unknown Phase

Extension Study of Carvedilol RCT Study

Beijing Friendship HospitalLiver Cirrhosis, Portal Hypertension

Start: 2021-01-08End: 2024-10-30Target: 240Updated: 2021-08-25

Acute Hemodynamic Response to Carvedilol in Predicting Survival in Acute on Chronic Liver Failure Patients - A Pilot Study.

Institute of Liver and Biliary Sciences, IndiaAcute on Chronic Liver Failure

Start: 2022-01-07End: 2024-12-31Target: 50Updated: 2022-01-11